A Case Report on Challenging Deep Vein Thrombosis

Life Sciences-Obstetrics and gynaecology

Authors

  • Dr.Logeswari B.M Assistant Professor, Department of Obstetrics and gynecology, Sree Balaji Medical College and Hospital, BIHER, Chromepet, Chennai-600044. https://orcid.org/0000-0002-1034-0936
  • Dr.Vatsala Shahi Junior Resident, Department of OBG, Sree Balaji Medical College and Hospital, BIHER Chromepet, Chennai-600044

DOI:

https://doi.org/10.22376/ijlpr.2023.13.6.L45-L50

Keywords:

Deep vein thrombosis, Pregnancy, Prothrombin time, /INR, LMWH

Abstract

In pregnancy, venous thromboembolism (VTE) remains a leading cause of direct maternal mortality. It is approximatelyfive times more common in pregnant women, with an incidence of 0.5-2 in 1000. The highest risk of deep venous thrombosis(DVT) leading to pulmonary embolism (PE) is during the postnatal period, especially after a cesarean section. A clinician who doesnot treat pregnant women regularly may not routinely identify pregnancy-specific risk factors for VTE. In patients with DVT,treatment with anticoagulation is associated with a high risk of bleeding during the immediate postpartum state, and patients dowell with monitored anticoagulation and proper supportive treatment, as described in this case report. We are reporting a caseof a 20-year-old primigravida who presented with labor pains at 39 (+6) weeks of gestation at Sree Balaji Medical College andHospital, Chrompet, Chennai. The patient had no comorbidities and did not report any past or family history of VTE. An emergencycesarean section was performed due to fetal distress, and on the first postoperative day, she developed swelling pain andtenderness in the left lower limb. Color Doppler ultrasound showed left anterior tibial vein thrombosis, following whichanticoagulant therapy was started with low molecular weight heparin. The patient was closely monitored for signs of bleeding orPE and was eventually discharged on oral anticoagulation. In conclusion, all women should be assessed for the risk factors of DVTduring the antenatal period, and early ambulation in the postoperative period is crucial to prevent such deadly complications.

References

Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706. doi 10.7326/0003-4819-143-10-200511150-00006, PMID 16287790.

Chopard R, Albertsen IE, Piazza G. Diagnosis and treatment of lower extremity venous thromboembolism: a review. JAMA. 2020 Nov 3;324(17):1765-76. Doi: 10.1001/jama.2020.17272, PMID 33141212.

Flessa HC, Glueck HI, Dritschilo A. Thromboembolic disorders in pregnancy: pathophysiology, diagnosis, and treatment, emphasizing heparin. Clin Obstet Gynecol. 1974 Dec;17(4):195-235. doi: 10.1097/00003081-197412000-00014, PMID 4615859.

Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynecology: The Scottish experience. Scott Med J. 1996 Jun;41(3):83-6. doi: 10.1177/003693309604100305, PMID 8807703.

Greer IA. Epidemiology, risk factors and prevention of venous thromboembolism in obstetrics and gynecology. Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):403-30. doi: 10.1016/s0950-3552(97)80019-3, PMID 9488783.

Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for treating and preventing obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0, PMID 26780741.

Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. Heparin therapy during pregnancy. Risks to the fetus and mother. Arch Intern Med. 1989;149(10):2233-6. doi: 10.1001/archinte.1989.00390100059015, PMID 2802889.

Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, et al. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: rationale and design of the Highlow study, a randomized trial of two doses. Thromb Res. 2016 Aug; 144:62-8. doi: 10.1016/j.thromres.2016.06.001, PMID 27289488.

Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 9th ed. 2012 Feb;141(2); Suppl: e691S-736S. doi: 10.1378/chest.11-2300, PMID 22315276.

Cotrufo M, De Feo M, De Santo LS, Romano G, Della Corte A, Renzulli A, et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol. 2002 Jan;99(1):35-40. doi: 10.1016/s0029-7844(01)01658-1, PMID 11777507.

James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and postpartum: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006 May;194(5):1311-5. doi: 10.1016/j.ajog.2005.11.008, PMID 16647915.

James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005 Jul;193(1):216-9. doi: 10.1016/j.ajog.2004.11.037, PMID 16021082.

Dargaud Y, Rugeri L, Fleury C, Battie C, Gaucherand P, Huissoud C, et al. Personalized thromboprophylaxis using a risk score for managing pregnancies with a high risk of thrombosis: a prospective clinical study. J Thromb Haemost. 2017 May;15(5):897-906. doi: 10.1111/jth.13660, PMID 28231636.

Tabaraii R, Farahmand H, Ahmadi J, Rezvan S, Arjmandnia MH, Yosefi M, et al. Deep vein thrombosis in pregnancy: a review article. J Vessel Circ. 2020;1(2):27-34. doi: 10.29252/jvesselcirc.1.2.27.

Published

2023-11-01

How to Cite

B.M, D. ., & Shahi, D. . (2023). A Case Report on Challenging Deep Vein Thrombosis: Life Sciences-Obstetrics and gynaecology. International Journal of Life Science and Pharma Research, 13(6), L45-L50. https://doi.org/10.22376/ijlpr.2023.13.6.L45-L50

Issue

Section

Case Study